PharmaShots Weekly Snapshot (March 09-13, 2020)
Published: Mar 13, 2020 | Tags: I-Mab, Initiate, Development, TJM2, Treating, Cytokine Release Syndrome, COVID-19
Published: Mar 13, 2020 | Tags: EMD Serono, Pfizer, Terminate, P-III, JAVELIN, Head and Neck 100, Study, Bavencio, CRT, Squamous Cell Carcinoma of the Head and Neck
Published: Mar 12, 2020 | Tags: Boehringer Ingelheim, Eli Lilly, Jardiance, empagliflozin, Receives, US, FDA, Fast Track Designation, Chronic Kidney Disease
Published: Mar 12, 2020 | Tags: AstraZeneca, MSD, Reports, Results, Cediranib, Lynparza, P-III, GY004 Study, Platinum-Sensitive, Relapsed Ovarian Cancer
Published: Mar 13, 2020 | Tags: Roche, cobas SARS-CoV-2 Test, Receives, US, FDA, Emergency Use Authorization, Identify, Corona Virus
6. ?AbCellera and Eli Lilly Collaborate to Co-develop Antibody Therapies Targeting COVID-19
Published: Mar 12, 2020 | Tags: AbCellera, Eli Lilly, Collaborate, Co-develop, Antibody Therapies, Targeting, COVID-19
7. Thermo Fisher Scientific Collaborates with Janssen to Co-Develop CDx for Multiple Cancer Indications
Published: Mar 12, 2020 | Tags: Thermo Fisher Scientific, Collaborates, Janssen, Co-Develop, CDx, Multiple, Cancer Indications
Published: Mar 12, 2020 | Tags: AbbVie, Dual Regimen, Receives, EC, Approval, Patients, Previously Untreated, Chronic Lymphocytic Leukemia
9. Novavax and Serum Institute of India Collaborate to Develop and Commercialize Vaccines for Malaria
Published: Mar 11, 2020 | Tags: Novavax, Serum Institute of India, Collaborate, Develop, Commercialize Vaccines, Malaria
Published: Mar 12, 2020 | Tags: Teva, Ajovy, fremanezumab, Receives, NICE Positive Recommendation, Prevention, Migraine, Adults
11. Henlius Reports the NMPAs Acceptance of IND for HLX14 (biosimilar, denosumab)
Published: Mar 09, 2020 | Tags: Henlius, Reports, NMPA, Acceptance, IND, HLX14, biosimilar, denosumab
Published: Mar 11, 2020 | Tags: Vir Biotechnology, Collaborates, NIH Vaccine Research Center, Advance, Development, mAbs, Against Coronavirus
Published: Mar 11, 2020 | Tags: BMS, Opdivo, nivolumab, Yervoy, ipilimumab, Receive, US, FDA, Approval, Patients, Hepatocellular Carcinoma
Published: Mar 10, 2020 | Tags: Takeda, Reports, Results, Ninlaro, ixazomib, P-III, TOURMALINE-MM2, Study, Transplant Ineligible, Patients, Multiple Myeloma
Published: Mar 11, 2020 | Tags: Janssen, JNJ-6372, Receives, US, FDA, Breakthrough Therapy Designation, Non-Small Cell Lung Cancer
Published: Mar 11, 2020 | Tags: Bridge Biotherapeutics, Signs, AI-Based, Research Agreement, Atomwise, Expand, Pellino Inhibitor Portfolio
Published: Mar 11, 2020 | Tags: Roche, CINtec PLUS Cytology, Receives, US, FDA, Approval, First, Biomarker-Based, Triage Test, Improve, Prevention, Cervical Cancer
18. CEPI Expands its Investment in the Development of Vaccine Against COVID-19
Published: Mar 10, 2020 | Tags: CEPI, Expands, Investment, Development, Vaccine, Against, COVID-19
19. Bora Pharmaceuticals to Acquire GSKs Facility in Canada
Published: Mar 09, 2020 | Tags: Bora Pharmaceuticals, Acquire, GSK, Facility, Canada
Published: Mar 10, 2020 | Tags: Novo Nordisk, Fiasp, insulin aspart injection, Receives, Health Canada, Approval, Children, Diabetes
Published: Mar 09, 2020 | Tags: Boehringer Ingelheim, Ofev, nintedanib, First Treatment, Chronic Fibrosing ILDs, Progressive Phenotype
22. ViiV Healthcare Renews its 2015 Collaboration with UNC-Chapel Hill to Discover a Cure for HIV
Published: Mar 09, 2020 | Tags: ViiV Healthcare, Renews, 2015, Collaboration, UNC-Chapel Hill, Five Years
23. ?Celltrion Reports Submission of MAA to EMA for CT-P17 (biosimilar, adalimumab)
Published: Mar 10, 2020 | Tags: Celltrion, Reports, Submission, MAA, EMA, CT-P17, biosimilar, adalimumab
Published: Mar 09, 2020 | Tags: AbbVie, Collaborates, Global Health Authorities, Investigate, Kaletra/Aluvia, lopinavir/ritonavir, Against, COVID-19
Published: Mar 09, 2020 | Tags: Biocon, Mylan, Report, US, FDA, Acceptance, BLA, Proposed Biosimilar, Avastin, bevacizumab
Published: Mar 09, 2020 | Tags: BMS, Reports, Results, Triple Regimen, P-III, ELOQUENT-1, Study, Patients, Newly Diagnosed, Untreated Multiple Myeloma
27. ?Zydus Signs a License Agreement with XOMA to Advance IL-2- Based Immuno-Oncology Therapy
Published: Mar 09, 2020 | Tags: Zydus, Signs, License Agreement, XOMA, Advance, IL-2-Based Immuno-Oncology Therapy
Published: Mar 06, 2020 | Tags: Abbvie, Maviret, glecaprevir/pibrentasvir, Receives, EC, Marketing Authorization, Eight-Week Regimen, Treatment-Naïve, Chronic HCV Patients, Genotype 3, Compensated Cirrhosis
29. Novartis Isturisa (osilodrostat) Receives the US FDAs Approval for Cushings Disease
Published: Mar 06, 2020 | Tags: Novartis, Isturisa, osilodrostat, Receives, US, FDA, Approval, Cushings Disease
Published: Mar 09, 2020 | Tags: Tetra Therapeutics, Shionogi, Expand, Existing, 2018, Collaboration, Develop, Commercialize, BPN14770
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com